Skip to main content
Clinical Trials/NCT03665623
NCT03665623
Completed
Not Applicable

A Prospective Multi-center Study on the Prediction of Preeclampsia by Comprehensive Markers in Early Pregnancy.

Peking Union Medical College Hospital1 site in 1 country11,741 target enrollmentDecember 1, 2017
ConditionsPre-Eclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre-Eclampsia
Sponsor
Peking Union Medical College Hospital
Enrollment
11741
Locations
1
Primary Endpoint
detection rate of preterm preeclampsia at fixed false positive rate 5%,10%,15%,20%
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Preeclampsia is one of the most serious complications in pregnancy that causes maternal death and preterm delivery. Series studies has show that the competing risk model developed by the Fetal Maternal FouNdation in early pregnancy has the potential to predict preeclampsia effectively but has show crowd difference. We aim to evaluate the performance of various screening model based on FMF model in Chinese population.

Detailed Description

The prospective multi-center observational study aimed to recruit at least 10,000 pregnant woman during the first trimester conducted among 12 medical centers in China. The medical history of each candidate was recorded , blood pressure was measured , blood sample was taken between 11 gestational weeks and 13+6 gestational weeks, to get the PlGF and PAPPA tested. Routine ultrasound was taken with measurement of the uterine artery pulsatility index. The results of the recruited patients were not released to the patients or the doctor. Pregnancy outcome was recorded as to whether the women develop preeclampsia , the SGA babies, or low birth Apgar score and other preeclampsia related adverse maternal and neonatal outcomes. The basic medical information, the mean artery pressure, the PlGF and PAPPA MOM, the UtA PI were used in combination to do the risk stratification, and to develop prediction model for Chinese people.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
August 31, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • gestational weeks between 11\~13+6
  • agreed to participate the study
  • live fetus at recruitment.

Exclusion Criteria

  • first obstetric visit beyond 14 gestational weeks
  • artificial abortion or spontaneous abortion before 20 weeks or lost to follow-up.
  • refused to participate the study.
  • fetus with major chromosome or structural abnormality

Outcomes

Primary Outcomes

detection rate of preterm preeclampsia at fixed false positive rate 5%,10%,15%,20%

Time Frame: at delivery and reviewed 60 days postpartum

PE defined according to the International Society for the Study of Hypertension in Pregnancy and the American College of Obstetricians and Gynecologists.

Secondary Outcomes

  • detection rate of small for gestational neonates at fixed risk cut of defined in primary outcome(at delivery)

Study Sites (1)

Loading locations...

Similar Trials